ANI Pharma Inc ANIP

$71.47 +1.48 (2.11%)

Valuation

Market cap
1,590,872,000
Revenue TTM
$883,370,000
Net income TTM
$78,340,000
P/E (trailing)
9.14
P/E (forward)
8.88
Profit margin
8.87%
Debt to equity
0.47

Trading

Volume
314,300
Avg volume
437,578
Day's range
$69.85 – $72.27
Shares out
22,730,000
Stochastic %K
84%
Beta
0.45
Analysts
Moderate Buy
Price target
$100.33

Price

Company profile

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The comp...

Show more

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Phone
218 634 3500
Website
https://www.anipharmaceuticals.com
Address
210 Main Street West, Baudette, United States

Latest news

Stocktwits

NoBossTae Nov 17, 6:21 PM
$XERS $MNKD $CORT $ANIP $AMPH 👩‍🚀🚀🌕
0 replies
Blaze321 Nov 11, 1:51 AM
$ANIP and $HRTX a match made in heaven. Get a deal done!
0 replies
Dy2ski Nov 6, 11:24 PM
$ANIP 52 week LOW! The money and rewards MGMT have been given for this pitiful performance... shameful. Was hoping that Gosebruch was nominated to the BOD to be the adult in the room and to lay the groundwork to sell to a more competent player that wouldn't be bungling Cortrophin but perhaps he's just there to protect the JP Morgan money that's being lended for the Egetis acquisition. Who knows.
0 replies
EarningsInsider Nov 5, 2:31 PM
https://www.marketbeat.com/earnings/reports/2026-11-5-ani-pharmaceuticals-inc-stock/ $ANIP ANI Pharmaceuticals Earnings Transcript
0 replies
OpenOutcrier Nov 5, 1:26 PM
$ANIP (-4.4% pre) ANI Pharma to buy Swedish biotech Egetis for $560M https://ooc.bz/l/120022
0 replies
Dy2ski Nov 5, 1:12 PM
$ANIP Now proves what incompetent management we have and why the stock has been utter garbage. Bungling the very Cortrophin expansion that they've been pumping all year. Unreal.
0 replies
d_risk Nov 5, 12:22 PM
$ANIP - ANI Pharmaceuticals Inc. - 10Q - Updated Risk Factors ANI disclosed a credit agreement for a senior bridge facility of up to $676 million in connection with its Egetis offer, maturing 364 days after initial funding. It warns that servicing the debt will require significant cash and may require asset sales, restructuring or additional financing if operating cash flow is insufficient. #Pharmaceuticals #MergersAndAcquisitions #FinancialRisk #ForeignExchangeExposure #PostMergerIntegration 🟢 Added 🟠 Removed https://d-risk.ai/ANIP/10-Q/2026-11-05
0 replies
StocktwitsEarnings Nov 5, 12:02 PM
$ANIP Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $2.70 up 32.35% YoY • Reported revenue of $290.78M up 27.64% YoY
0 replies